deltatrials
Completed PHASE1 INTERVENTIONAL 18-arm NCT04602221

A Study in Healthy Men to Test Whether BI 409306, BI 425809 or Lamotrigine Can Reverse the Memory Problems Caused by Ketamine

A Randomized, Placebo Controlled, Double-blind, Double-dummy Three-way Cross Over Trial to Investigate the Effect of BI 409306, BI 425809 and Lamotrigine on Ketamine-induced Cognitive Deficits in Healthy Male Subjects

Sponsor: Boehringer Ingelheim

Conditions Healthy
Interventions BI 409306 BI 425809 Lamotrigine Placebo
Updated 23 times since 2020 Last updated: Aug 10, 2023 Started: Dec 1, 2020 Primary completion: Aug 1, 2022 Completion: Aug 12, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04602221, this PHASE1 trial focuses on Healthy and remains completed. Sponsored by Boehringer Ingelheim, it has been updated 23 times since 2020, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Nov 2020 – ~Dec 2020 · 30 days · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Mar 2021 · 28 days · monthly snapshot~Mar 2021 – ~Apr 2021 · 31 days · monthly snapshot~Apr 2021 – ~May 2021 · 30 days · monthly snapshot~May 2021 – ~Jun 2021 · 31 days · monthly snapshot~Jun 2021 – ~Sep 2021 · 3 months · monthly snapshot~Sep 2021 – ~Oct 2021 · 30 days · monthly snapshot~Oct 2021 – ~Nov 2021 · 31 days · monthly snapshot~Nov 2021 – ~Dec 2021 · 30 days · monthly snapshot~Dec 2021 – ~Jan 2022 · 31 days · monthly snapshot~Jan 2022 – ~Feb 2022 · 31 days · monthly snapshot~Feb 2022 – ~Mar 2022 · 28 days · monthly snapshot~Mar 2022 – ~Apr 2022 · 31 days · monthly snapshot~Apr 2022 – ~May 2022 · 30 days · monthly snapshot~May 2022 – ~Jun 2022 · 31 days · monthly snapshot~Jun 2022 – ~Jul 2022 · 30 days · monthly snapshot~Jul 2022 – ~Sep 2022 · 2 months · monthly snapshot~Sep 2022 – ~Apr 2024 · 19 months · monthly snapshot~Apr 2024 – ~Jul 2024 · 3 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

23 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Apr 2024 — Jul 2024 [monthly]

    Completed PHASE1

  4. Sep 2022 — Apr 2024 [monthly]

    Completed PHASE1

    Status: Recruiting → Completed

  5. Jul 2022 — Sep 2022 [monthly]

    Recruiting PHASE1

▶ Show 18 earlier versions

  1. Jun 2022 — Jul 2022 [monthly]

    Recruiting PHASE1

  2. May 2022 — Jun 2022 [monthly]

    Recruiting PHASE1

  3. Apr 2022 — May 2022 [monthly]

    Recruiting PHASE1

  4. Mar 2022 — Apr 2022 [monthly]

    Recruiting PHASE1

  5. Feb 2022 — Mar 2022 [monthly]

    Recruiting PHASE1

  6. Jan 2022 — Feb 2022 [monthly]

    Recruiting PHASE1

  7. Dec 2021 — Jan 2022 [monthly]

    Recruiting PHASE1

  8. Nov 2021 — Dec 2021 [monthly]

    Recruiting PHASE1

  9. Oct 2021 — Nov 2021 [monthly]

    Recruiting PHASE1

  10. Sep 2021 — Oct 2021 [monthly]

    Recruiting PHASE1

  11. Jun 2021 — Sep 2021 [monthly]

    Recruiting PHASE1

  12. May 2021 — Jun 2021 [monthly]

    Recruiting PHASE1

  13. Apr 2021 — May 2021 [monthly]

    Recruiting PHASE1

  14. Mar 2021 — Apr 2021 [monthly]

    Recruiting PHASE1

  15. Feb 2021 — Mar 2021 [monthly]

    Recruiting PHASE1

  16. Jan 2021 — Feb 2021 [monthly]

    Recruiting PHASE1

    Status: Not Yet Recruiting → Recruiting

  17. Dec 2020 — Jan 2021 [monthly]

    Not Yet Recruiting PHASE1

  18. Nov 2020 — Dec 2020 [monthly]

    Not Yet Recruiting PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Boehringer Ingelheim
Data source: Boehringer Ingelheim

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations